Send to a Friend Font Size: Increase Decrease

OrbiMed Advisors

OrbiMed Advisors's Portfolio

Last Updated on 5/16/11 @ 11:13am

Ticker	# of Shares	Price	Value
	73,114,592	$195.32	$14,280,742,110
	22,362,850	$195.32	$4,367,911,862
	17,233,668	$195.32	$3,366,080,034
	14,567,176	$195.32	$2,845,260,817
	9,033,726	$195.32	$1,764,467,363
	8,998,338	$195.32	$1,757,555,379
	8,322,140	$195.32	$1,625,480,385
	8,009,729	$195.32	$1,564,460,269
	7,619,135	$195.32	$1,488,169,449
View Additional Portfolio Information »

http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.

Login to help us fill in information about this entity.

View Older Stories View More Recent Stories

Feb 13, 2017 01:49PM Form SC 13G/A IRONWOOD PHARMACEUTICALS Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:47PM Form SC 13G/A IMPAX LABORATORIES INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:47PM Form SC 13G/A Insys Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:44PM Form SC 13G/A INSMED Inc Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:42PM Form SC 13G/A INFINITY PHARMACEUTICALS Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:41PM Form SC 13G/A eHealth, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:39PM Form SC 13G/A DYNAVAX TECHNOLOGIES Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:38PM Form SC 13G/A Sierra Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:36PM Form SC 13G/A CONNECTURE INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:35PM Form SC 13G/A ARRAY BIOPHARMA INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:35PM Form SC 13G/A CERUS CORP Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:32PM Form SC 13G/A AFFYMETRIX INC Filed by: ORBIMED ADVISORS LLC
Feb 13, 2017 01:30PM Form SC 13G/A ACHILLION PHARMACEUTICAL Filed by: ORBIMED ADVISORS LLC
Feb 10, 2017 04:14PM venBio Comments on Immunomedics Partnership Announcement
Feb 7, 2017 04:56PM Form SC 13D/A Roka BioScience, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 6, 2017 06:58AM ISS Endorses Full Slate of venBio Nominees at Immunomedics
Feb 3, 2017 01:25PM Form SC 13G ObsEva SA Filed by: ORBIMED ADVISORS LLC
Feb 2, 2017 02:25PM OrbiMed Comments on Immunomedics Proxy Contest
Jan 27, 2017 01:10PM Form SC 13D/A Affimed N.V. Filed by: ORBIMED ADVISORS LLC
Jan 20, 2017 04:25PM Form 4 ViewRay, Inc. For: Jan 18 Filed by: ORBIMED ADVISORS LLC
Jan 20, 2017 04:20PM Form SC 13D/A ViewRay, Inc. Filed by: ORBIMED ADVISORS LLC
Jan 18, 2017 04:17PM ViewRay (VRAY) Raises $26.1 Million in Private Placement of Common Stock and Warrants
Jan 18, 2017 04:01PM ViewRay Raises $26.1 Million in Private Placement
Jan 17, 2017 08:38AM PlacementTracker Publishes 2016 Private Placement Market League Tables
Jan 12, 2017 11:12AM Form SC 13D/A Loxo Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
Dec 30, 2016 04:22PM Form 3 Nabriva Therapeutics AG For: Dec 30 Filed by: ORBIMED ADVISORS LLC
Dec 12, 2016 12:00PM Sonendo® Closes $35 Million Equity Financing Round
Dec 12, 2016 09:00AM Treato Appoints Healthcare Industry Veteran Allen Kamer to its Board of Directors
Dec 8, 2016 05:10PM Form SC 13G/A SUNOVION CNS DEVELOPMENT Filed by: ORBIMED ADVISORS LLC
Dec 1, 2016 04:56PM Form SC 13D/A RESPONSE BIOMEDICAL CORP Filed by: ORBIMED ADVISORS LLC
Nov 29, 2016 12:42PM Response Biomedical Corp. Completes Going-Private Transaction
Nov 16, 2016 10:22AM Inspire Medical Systems Completes 1,000th Implant, Names Marilyn Carlson Nelson to the Board, and Completes Series F Financing
Nov 14, 2016 05:07PM Form 13F-HR ORBIMED ADVISORS LLC For: Sep 30
Nov 14, 2016 01:57PM Form SC 13D/A Roka BioScience, Inc. Filed by: ORBIMED ADVISORS LLC
Nov 2, 2016 11:30AM FACIT Start-up Turnstone Biologics Closes USD $41M Financing
Oct 24, 2016 05:17PM Form SC 13D/A Ascendis Pharma A/S Filed by: ORBIMED ADVISORS LLC
Oct 24, 2016 09:50AM Unilife Corp. (UNIS) Issues Accelerated Convertible Note to Amgen
Oct 17, 2016 08:38AM PlacementTracker Publishes Q3 2016 Private Placement Market League Tables
Sep 26, 2016 04:08PM Form SC 13D/A Affimed N.V. Filed by: ORBIMED ADVISORS LLC
Sep 23, 2016 04:16PM Form 4 Roka BioScience, Inc. For: Sep 21 Filed by: ORBIMED ADVISORS LLC
Sep 23, 2016 04:09PM Form SC 13D/A Roka BioScience, Inc. Filed by: ORBIMED ADVISORS LLC
Sep 16, 2016 05:00PM Response Biomedical Corp. Receives Shareholder Approval of Going-Private Transaction
Sep 16, 2016 04:14PM Form SC 13G/A Cynapsus Therapeutics Filed by: ORBIMED ADVISORS LLC
Aug 26, 2016 04:50PM Form SC 13D ViewRay, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 22, 2016 04:04PM Inspire Medical Systems Reaches over 1,000 Implants for the Treatment of Obstructive Sleep Apnea
Aug 22, 2016 06:29AM ViewRay, Inc. (VRAY) Enters $13.75M Common Stock Private Placement
Aug 19, 2016 05:51PM ViewRay Announces $13.75 Million Private Placement
Aug 15, 2016 04:19PM Form 13F-HR ORBIMED ADVISORS LLC For: Jun 30
Aug 12, 2016 05:22PM Form SC 13D SteadyMed Ltd. Filed by: ORBIMED ADVISORS LLC
Aug 12, 2016 04:51PM Form 3 SteadyMed Ltd. For: Aug 04 Filed by: ORBIMED ADVISORS LLC

View More Recent Stories View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed